BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1977807)

  • 1. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
    Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
    Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
    Senaldi G; Lupoli S; Vergani D; Black CM
    Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
    Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation by cellulosic dialysis membranes.
    Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
    J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical and alternative complement pathway activation in paracoccidioidomycosis.
    de Messias IT; Mohren D
    J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and immune complexes in early congenital HIV infection.
    Jarvis JN; Taylor H; Iobidze M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):480-5. PubMed ID: 7697445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J; Sigfusson A
    J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in neonatal infection.
    Peakman M; Senaldi G; Liossis G; Gamsu HR; Vergani D
    Arch Dis Child; 1992 Jul; 67(7 Spec No):802-7. PubMed ID: 1519979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
    Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
    J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome.
    Kuypers DR; Lerut E; Evenepoel P; Maes B; Vanrenterghem Y; Van Damme B
    Transplantation; 2003 Jul; 76(1):102-8. PubMed ID: 12865794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
    Hopkinson ND; Powell RJ
    J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the complement system in primary sclerosing cholangitis.
    Senaldi G; Donaldson PT; Magrin S; Farrant JM; Alexander GJ; Vergani D; Williams R
    Gastroenterology; 1989 Dec; 97(6):1430-4. PubMed ID: 2583409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
    Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
    Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.